{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:44:31Z","timestamp":1781592271402,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pfizer Japan Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jiac.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T19:43:14Z","timestamp":1417290194000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan"],"prefix":"10.1016","volume":"21","author":[{"given":"Hiroshige","family":"Mikamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Matsumizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiomi","family":"Nakazuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.10.005_bib1","first-page":"238","article-title":"The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections","volume":"96","author":"Cosar","year":"1959","journal-title":"Ann Inst Pasteur"},{"key":"10.1016\/j.jiac.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","article-title":"A\u00a0therapeutic review and update","volume":"54","author":"Freeman","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2014.10.005_bib3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","article-title":"Why metronidazole is active against both bacteria and parasites","volume":"43","author":"Samuelson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-2952(86)90553-8","article-title":"Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity","volume":"35","author":"Goldman","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jiac.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/AAC.01038-10","article-title":"In\u00a0vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria","volume":"55","author":"Tran","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib6","series-title":"Harrison's principles of internal medicine","article-title":"Part 8 infectious diseases, chapter 164 infections due to mixed anaerobic organisms","author":"Kasper","year":"2011"},{"key":"10.1016\/j.jiac.2014.10.005_bib7","series-title":"The Sanford guide to antimicrobial therapy 2013","year":"2013"},{"key":"10.1016\/j.jiac.2014.10.005_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.10.005_bib9","series-title":"Sexually transmitted diseases treatment guidelines","author":"Centers for Disease Control and Prevention","year":"2010"},{"key":"10.1016\/j.jiac.2014.10.005_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.10.005_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10156-012-0532-2","article-title":"PCR-based detection of resistance genes in anaerobic bacteria isolated from intra-abdominal infections","volume":"19","author":"Tran","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10156-012-0509-1","article-title":"Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan","volume":"18","author":"Takesue","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(99)00164-8","article-title":"Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options","volume":"15","author":"Falagas","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2014.10.005_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2012.07.004","article-title":"Antibiotic susceptibility profiles of oral pathogens","volume":"40","author":"Veloo","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2014.10.005_bib15","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/AAC.06428-11","article-title":"Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic\u00a0infiltrates and abscesses","volume":"56","author":"Sobottka","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib16","first-page":"49","article-title":"Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008","volume":"65","author":"Yoshida","year":"2012","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2014.10.005_bib17","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"L\u00f6fmark","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.10.005_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000658-198008000-00015","article-title":"Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis","volume":"192","author":"Smith","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.jiac.2014.10.005_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/39.5.631","article-title":"A\u00a0multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections","volume":"39","author":"Mehtar","year":"1997","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.anaerobe.2004.04.003","article-title":"In\u00a0vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora","volume":"10","author":"Finegold","year":"2004","journal-title":"Anaerobe"},{"key":"10.1016\/j.jiac.2014.10.005_bib21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4269\/ajtmh.2009.80.827","article-title":"Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus","volume":"80","author":"Campbell","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2014.10.005_bib22","first-page":"557","article-title":"In\u00a0vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral actinomyces","volume":"33","author":"LeCorn","year":"2007","journal-title":"J\u00a0Endod"},{"key":"10.1016\/j.jiac.2014.10.005_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1600-0463.2012.02905.x","article-title":"Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates","volume":"120","author":"Olsson","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.jiac.2014.10.005_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2011.12.022","article-title":"Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF","volume":"18","author":"Trevi\u00f1o","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.jiac.2014.10.005_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2012.10.001","article-title":"Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey","volume":"41","author":"S\u00f3ki","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2014.10.005_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10156-010-0147-4","article-title":"Chapter 2-6-1. Anaerobic infections (individual fields): female genital infections. In: guidelines for diagnosis and treatment of anaerobic infections","volume":"17","author":"Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib27","series-title":"Harrison's principles of internal medicine","article-title":"Part 8 infectious diseases, chapter 130 sexually transmitted infections: overview and clinical approach","author":"Marrazzo","year":"2011"},{"key":"10.1016\/j.jiac.2014.10.005_bib28","series-title":"Harrison's principles of internal medicine","article-title":"Part 8 infectious diseases, chapter 127 intraabdominal infections and abscesses","author":"Baron","year":"2011"},{"key":"10.1016\/j.jiac.2014.10.005_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00534-012-0572-0","article-title":"TG13 antimicrobial therapy for acute cholangitis and cholecystitis","volume":"20","author":"Gomi","year":"2013","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2014.10.005_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10156-010-0139-4","article-title":"Chapter 2\u20133. Anaerobic infections (individual fields): central nervous system infections (brain abscess, subdural abscess, epidural abscess and bacterial meningitis). In: guidelines for diagnosis and treatment of anaerobic infections","volume":"17","author":"Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.10.005_bib31","series-title":"Harrison's principles of internal medicine","article-title":"Part 8 infectious diseases, chapter 121 approach to the acutely Ill infected febrile patient","author":"Barlam","year":"2011"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:53:48Z","timestamp":1761159228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1341321X14003584"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.10.005","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}